In June 2016 the United States Anti-Doping Agency (USADA) has reported an anti-doping rule violation against the Athlete Sam Tierney after his sample tested positive for the prohibited substance vilanterol.
At the time of the violation the Athlete used an inhaler without an approved TUE and a TUE application hereafter to USADA was denied.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and was heard for the American Arbitration Association (AAA) Commercial Arbitration Tribunal.
The Athlete admitted the violation and stated that in May 2016 he suffered from acute bronchitis and therefore used prescribed antibiotics and the inhaler. He didn’t research the ingredients of medication before using and he did not understand that he had been prescribed asthma medicine.
Considering the circumstances the Sole Arbitrator finds that the Athlete has established No Significant Fault or Negligence for the lowest possible sanction available.
Therefore the AAA Tribunal Panel decides on 8 July 2016 to impose a reprimand on the Athlete without a period of ineligibility.
